{
    "code": "01038284",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01038284",
    "time": "2019-02-15 03:04:14",
    "許可證字號": "衛署藥製字第038284號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/11\/18",
    "發證日期": "83\/11\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103828409",
    "中文品名": "保得命注射液１２．５公絲\/公撮（多保他命）",
    "英文品名": "BUTAMINE INJECTION 12.5MG\/ML (DOBUTAMINE)",
    "適應症": "增強心肌收縮力而適用於短期治療器質性心臟病、心臟外科心術引起心肌收縮力抑制而導致之心臟代償機能衰竭。",
    "劑型": "270注射劑",
    "包裝": "20公撮小瓶 100支裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DOBUTAMINE(HCL)"
    ],
    "限制項目": "01國　產",
    "申請商名稱": "6201091130  瑞安大藥廠股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "6105200026  瑞士藥廠股份有限公司新市廠",
        "製造廠廠址": "台南市新市區中山路182號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2404309210",
            "成分名稱": "DOBUTAMINE (HCL)",
            "含量描述": "12.5",
            "含量": "12.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Butmine_INS_02_201503-104-11-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038284&Seq=002&Type=9"
        },
        {
            "title": "Butamine_實體外觀-104-10-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038284&Seq=001&Type=8"
        }
    ]
}